Skip to main content

Carisma Therapeutics to get $80M in cash and investment through new deal with Moderna

Moderna will make a $45 million upfront payment and invest another $35 million in the Penn spinout.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.